Sort
15,842 grants matching “pancreatic cancer”
Biospecimens and Patient-derived xenografts
$161,494David Marc Weinstock · Massachusetts Institute Of Technology · U54 · FY2020 · CA
Targeting RAGE in pancreatic cancer
$161,494Esther Amalia Guzman · Florida Atlantic University · R21 · FY2013 · CA
Temporally controlled oncogene expression in a novel pancreatic cancer model
$161,494Kay-Uwe Wagner · University Of Nebraska Medical Center · R21 · FY2012 · CA
EXPERIMENTAL PATHOLOGY CORE
$161,418Gerald C Chu · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
An epigenetic switch controlling pancreatic cancer susceptibility
$161,397Lewis C Murtaugh · University Of Utah · R21 · FY2014 · CA
Targeting Pancreatic Cancer with Aptamers to the CCK-B Receptor
$161,397Gail L. Matters · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2014 · CA
Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer
$161,354Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Optical probe for microscopic cancer identification in minute structures
$161,299Martin Feldman · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2010 · CA
Outreach Core
$161,054Lourdes Baezconde Garbanati · University Of Southern California · U54 · FY2022 · CA
Target Stat3 in pancreatic cancer using novel small molecule inhibitors
$161,040Jiayuh Lin · Research Inst Nationwide Children'S Hosp · R21 · FY2010 · CA
Anaerobic Bacteria as Therapeutic Agents for Metastatic
$161,025Savio L Woo · Icahn School Of Medicine At Mount Sinai · R21 · FY2006 · CA
Proteomics Shared Resource
$161,025Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2022 · CA
Non-invasive sampling of DNA markers for pancreatic cancer screening
$161,005Dmitri Simberg · University Of California, San Diego · R21 · FY2012 · CA
Core B - Biosample Core
$160,981Thomas J. Giordano · University Of Michigan At Ann Arbor · P50 · FY2012 · CA
In vivo Image Guided Cancer Therapy
$160,975Anna Moore · Massachusetts General Hospital · R21 · FY2007 · CA
Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer.
$160,950Channing J Der · Univ Of North Carolina Chapel Hill · R21 · FY2012 · CA
Arid1a loss accelerates pancreatic ductal adenocarcinoma precursor formation
$160,920Sam C. Wang · Ut Southwestern Medical Center · K08 · FY2021 · CA
Mouse Model of Pancreatic Cancer Progression-Maintenance
$160,920Nabeel Bardeesy · Massachusetts General Hospital · K01 · FY2007 · CA
Arid1a loss accelerates pancreatic ductal adenocarcinoma precursor formation
$160,920Sam C. Wang · Ut Southwestern Medical Center · K08 · FY2020 · CA
Arid1a loss accelerates pancreatic ductal adenocarcinoma precursor formation
$160,920Sam C. Wang · Ut Southwestern Medical Center · K08 · FY2022 · CA
Novel Combination Therapy Against Pancreatic Cancer
$160,903Maneesh Jain · University Of Nebraska Medical Center · R21 · FY2011 · CA
Proteomics Shared Resource
$160,901Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2021 · CA
Proteomics Shared Resource
$160,901Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2023 · CA
Tissue Modeling & Drug Development Shared Resources Core
$160,888Paul Okunieff · University Of Florida · U54 · FY2023 · CA
Lymphangiogeneis and Metastasis During Pancreatic Cancer Progression
$160,869Michael A Hollingsworth · University Of Nebraska Medical Center · U54 · FY2014 · CA